INTERNATIONAL PATENT: ZHEJIANG SHIMAI PHARMACEUTICAL CO., LTD. FILES APPLICATION FOR "ANTIBODIES AGAINST DLL3 AND USES THEREOF"

GENEVA, Feb. 24 -- ZHEJIANG SHIMAI PHARMACEUTICAL CO., LTD. (20th Floor, Huachuang Bldg., 511 Jianye Road, BinjiangHangzhou, Zhejiang 310000) filed a patent application (PCT/CN2023/112911) for "ANTIBODIES AGAINST DLL3 AND USES THEREOF" on Aug 14, 2023. With publication no. WO/2025/035356, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XIAO, Zuoxiang (Zhejiang Shimai Pharmaceutical Co., Ltd., 20th Floor, Huachuang Bldg., 511 Jianye Road, BinjiangHangzhou, Zhejiang 310000), ZHOU, Dongwen (Zhejiang Shimai Pharmaceutical Co....